300254 仟源医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.0014.288-20.358-14.326-34.910
总资产报酬率 ROA (%)1.2571.670-7.619-5.496-14.566
投入资产回报率 ROIC (%)1.6642.145-9.679-7.129-19.018

边际利润分析
销售毛利率 (%)65.95967.78869.73569.66869.171
营业利润率 (%)9.7295.024-13.883-8.553-37.156
息税前利润/营业总收入 (%)15.72110.612-5.669-1.958-28.867
净利润/营业总收入 (%)13.1646.096-11.812-8.012-33.083

收益指标分析
经营活动净收益/利润总额(%)51.561-7.07073.038111.51181.865
价值变动净收益/利润总额(%)0.00037.7763.811-20.8290.075
营业外收支净额/利润总额(%)29.22027.361-27.853-21.525-5.605

偿债能力分析
流动比率 (X)0.9330.9630.8470.9401.182
速动比率 (X)0.6480.6760.6750.6690.932
资产负债率 (%)45.57945.68153.94551.23351.535
带息债务/全部投入资本 (%)36.71535.98448.27920.571--
股东权益/带息债务 (%)150.869154.16893.972242.480188.299
股东权益/负债合计 (%)91.90991.67367.26875.34974.048
利息保障倍数 (X)7.9572.871-1.093-0.385-4.570

营运能力分析
应收账款周转天数 (天)49.19247.10649.50762.7050.000
存货周转天数 (天)173.283156.661151.840147.2290.000